Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Prostate”

568 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 568 results

Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Testing effectiveness (Phase 2)Study completedNCT00271687
What this trial is testing

A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer

Who this might be right for
Prostatic NeoplasmsNeoplasm MetastasisPalliative Care
AHS Cancer Control Alberta 30
Early research (Phase 1)Ended earlyNCT04740034
What this trial is testing

AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 42
Early research (Phase 1)Study completedNCT04087174
What this trial is testing

A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
AstraZeneca 27
Not applicableLooking for participantsNCT05933876
What this trial is testing

The Impact of Radiotherapy on Oligometastatic Cancer

Who this might be right for
MetastasisMetastatic Breast CancerMetastatic Prostate Cancer+2 more
Institut Investigacio Sanitaria Pere Virgili 2,000
Testing effectiveness (Phase 2)Study completedNCT01431391
What this trial is testing

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Who this might be right for
Prostatic NeoplasmProstate CancerProstatic Adenocarcinoma
Dendreon 68
Not applicableNot Yet RecruitingNCT07238959
What this trial is testing

Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate Cancer

Who this might be right for
Benign Prostate Hypertrophy(BPH)Prostate Cancer (Diagnosis)Prostate Neoplasm
Shanghai Changzheng Hospital 1,100
Early research (Phase 1)Study completedNCT03205176
What this trial is testing

AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas

Who this might be right for
Malignant Solid TumorsLymphomaOvarian Cancer+3 more
AstraZeneca 49
Large-scale testing (Phase 3)Study completedNCT01322490
What this trial is testing

A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Bavarian Nordic 1,297
Testing effectiveness (Phase 2)Study completedNCT00106418
What this trial is testing

A Research Study for Patients With Prostate Cancer

Who this might be right for
Prostate CancerMetastases
Celgene 35
Early research (Phase 1)Looking for participantsNCT04485013
What this trial is testing

TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

Who this might be right for
Cancer
Tizona Therapeutics, Inc 240
Not applicableLooking for participantsNCT06982469
What this trial is testing

High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy

Who this might be right for
Prostate CancerProstatectomyLocal Recurrence of Malignant Tumor of Prostate+2 more
Clinica Universidad de Navarra, Universidad de Navarra 20
Large-scale testing (Phase 3)Active Not RecruitingNCT02194842
What this trial is testing

Phase III Radium 223 mCRPC-PEACE III

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 446
Not applicableActive Not RecruitingNCT03438552
What this trial is testing

Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence

Who this might be right for
Local Recurrence of Malignant Tumor of Prostate
UNICANCER 57
Early research (Phase 1)WithdrawnNCT01320787
What this trial is testing

18-F-Fluoroacetate as PET Imaging Agent

Who this might be right for
Brain CancerBreast CancerProstate Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Early research (Phase 1)Temporarily pausedNCT01337518
What this trial is testing

A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasm
Enzon Pharmaceuticals, Inc. 150
Testing effectiveness (Phase 2)WithdrawnNCT05191017
What this trial is testing

Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC

Who this might be right for
Prostate CancerProstatic CancerCancer of Prostate+5 more
Nuvation Bio Inc.
Testing effectiveness (Phase 2)Study completedNCT01289067
What this trial is testing

Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca

Who this might be right for
Prostate Cancer
William K. Oh 13
Testing effectiveness (Phase 2)Ended earlyNCT05716295
What this trial is testing

A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Medikine, Inc. 26
Load More Results